PDPN and breast cancer: In addition, Tejchman and colleagues [27] proposed that, in a hypoxic environment, podoplanin-positive CAFs facilitate the escape of CCR7-positive breast cancer cells from immunosurveillance by binding of podoplanin to CCL21.